Results 21 to 30 of about 11,985 (168)

Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study

open access: yesBMC Medical Imaging, 2019
Background Diagnosis of giant cell arteritis by temporal artery biopsy is time-consuming and visual loss lies in the first week after its diagnosis. The purpose of the study was to test the hypothesis that ultrasound can reduce the risk of overdiagnosis ...
Quan Zou, Sumei Ma, Xinghu Zhou
doaj   +1 more source

Alternating Transient Monocular Vision Loss Due to Giant Cell Arteritis

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Giant cell arteritis is a systemic granulomatous vasculitis commonly involving the temporal artery and associated with visual deficits. The most common ocular presentation of giant cell arteritis involves anterior ischemic ocular neuropathy with sudden ...
Benjamin J. McCormick   +4 more
doaj   +1 more source

Hepatic Giant Cell Arteritis and Polymyalgia Rheumatica

open access: yesCanadian Journal of Gastroenterology, 1994
Polymyalgia rheumatica (PMR) is a clinical syndrome of the elderly characterized by malaise, proximal muscle aching and stiffness, low grade fever, elevated erythrocyte sedimentation rare and the frequent association with temporal giant cell arteritis ...
Donald R Duerksen   +2 more
doaj   +1 more source

Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Polymyalgia rheumatica and giant cell arteritis are systemic inflammatory conditions of the elderly. Polymyalgia rheumatica classically presents as a bilateral proximal muscle pain and stiffness syndrome.
Liyana Arachchige Dona Thulini Madubashini   +2 more
doaj   +1 more source

Giant Cell Arteritis Presenting With Ocular Symptoms: Clinical Characteristics and Multimodal Imaging in a Chinese Case Series

open access: yesFrontiers in Medicine, 2022
PurposeTo evaluate demographic and clinical characteristics of a Chinese population with giant cell arteritis using multimodal imaging focusing on ophthalmic examinations.DesignRetrospective observational case series.Materials and MethodsIn the neuro ...
Qian Chen   +10 more
doaj   +1 more source

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang   +10 more
wiley   +1 more source

Coexistence of giant cell arteritis and subacute thyroiditis: A case report and literature review

open access: yesJournal of International Medical Research
Giant cell arteritis and subacute thyroiditis are often regarded as clinically distinct diseases with differing pathogenesis. We report a rare case of coexisting giant cell arteritis and subacute thyroiditis that were both successfully managed using ...
Cheng Xu, Yongmei Han
doaj   +1 more source

Giant Cell Arteritis: A review of current knowledge and new biological treatment options

open access: yesJournal of Education, Health and Sport
Introduction and objective  Giant cell arteritis (GCA) is the most common primary systemic vasculitis in Europe. It mainly affects individuals over the age of fifty, its incidence increases with age. The most common clinical manifestation is bilateral
Aleksandra Cygnarowicz
doaj   +1 more source

Synthesis of new derivatives of 9-aryl-3-ethoxycarbonylmethyl-2,4,5(9H)-trioxo- 7,8-dihydroimidazo[1,2-a][1,3,5]triazepine

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2012
The pathophysiology of giant cell arteritis (temporal arteritis) is not fully understood. The disease frequently presents itself with nonspecific complaints like headache, low-grade fever of the unknown origin.
Marzena Rzadkowska   +2 more
doaj   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy